LON:MDC

Mediclinic International Share Forecast, Price & News

GBX 297.60

+1.20 (+0.40 %)

(As of 05/17/2021 01:20 PM ET)

Add

Compare

Today's Range

296.20

▼

302.20

50-Day Range

282.60

▼

319

52-Week Range

241.40

▼

343

Volume220,956 shs

Average Volume481,766 shs

Market Capitalization£2.19 billion

P/E RatioN/A

Dividend Yield3.12%

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

About Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 hospitals, 2 day case clinics, 3 outpatient clinics, and 110 theatres with approximately 1,893 inpatient beds in Switzerland; 52 hospitals, 10 day case clinics, 8 sub-acute hospitals, and 305 theatres in South Africa and Namibia with approximately 8,792 inpatient beds; and 7 hospitals, 2 day case clinics, 18 outpatient clinics, and 38 theatres with approximately 927 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

Mediclinic International (LON:MDC) Trading 2.2% Higher
May 7, 2021 | americanbankingnews.com

Mediclinic International's (LON:MDC) Shareholders Are Down 65% On Their Shares
May 4, 2021 | finance.yahoo.com

Mediclinic annual revenue set to decline despite second-half recovery
April 17, 2021 | lse.co.uk

Is Mediclinic International plc (LON:MDC) Popular Amongst Institutions?
March 12, 2021 | finance.yahoo.com

Mediclinic's Hirslanden Issues CHF145 million Bond For Refinancing
February 4, 2021 | lse.co.uk

We Might See A Profit From Mediclinic International plc (LON:MDC) Soon
January 26, 2021 | finance.yahoo.com

UPDATE 1-South Africa's total COVID-19 cases cross 1 million mark
December 29, 2020 | fr.reuters.com

Virus Surge Puts South African Hospitals Under ‘Severe Strain’
December 21, 2020 | bloomberg.com

Why Mediclinic International's (LON:MDC) CEO Pay Matters
December 21, 2020 | finance.yahoo.com

South African Hospitals Warn of Virus Surge in Holiday Season
November 26, 2020 | bloomberg.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON

Industry Medical Care

Sub-IndustryN/A

SectorMedical

Current SymbolLON:MDC

Previous SymbolLON:ANH

CUSIPN/A

CIKN/A

Webwww.mediclinic.com

Phone+44-20-79549600

Employees32,291

Year FoundedN/A

Sales & Book Value

Annual Sales£2.98 billion

Price / Sales0.74

Cash FlowGBX 35.14 per share

Price / Cash Flow8.47

Book ValueGBX 393.60 per share

Price / Book0.76

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity Ratio87.89

Current Ratio1.58

Quick Ratio1.42

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E Ratio0.10

P/E GrowthN/A

Miscellaneous

Outstanding Shares737,244,000

Market Cap£2.19 billion

Next Earnings Date5/26/2021 (Estimated)

OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

1.2 Analyst's Opinion

Consensus Rating
Mediclinic International has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 321.50, Mediclinic International has a forecasted upside of 8.0% from its current price of GBX 297.60.
Amount of Analyst Coverage
Mediclinic International has received no research coverage in the past 90 days.

2.0 Community Rank

Outperform Votes
Mediclinic International has received 214 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Mediclinic International has received 320 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Mediclinic International has received 59.93% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Mediclinic International and other stocks. Vote “Outperform” if you believe MDC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Mediclinic International pays a meaningful dividend of 3.12%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Mediclinic International does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Mediclinic International insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Mediclinic International is -5.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Mediclinic International is -5.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Mediclinic International has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Mediclinic International (LON:MDC) Frequently Asked Questions

Is Mediclinic International a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Mediclinic International stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View analyst ratings for Mediclinic International or view top-rated stocks.

What stocks does MarketBeat like better than Mediclinic International?

Wall Street analysts have given Mediclinic International a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mediclinic International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Mediclinic International's next earnings date?

Mediclinic International is scheduled to release its next quarterly earnings announcement on Wednesday, May 26th 2021.
View our earnings forecast for Mediclinic International.

How has Mediclinic International's stock price been impacted by Coronavirus?

Mediclinic International's stock was trading at GBX 335.70 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MDC shares have decreased by 11.3% and is now trading at GBX 297.60.
View which stocks have been most impacted by COVID-19.

Is Mediclinic International a good dividend stock?

Mediclinic International pays an annual dividend of GBX 0.03 per share and currently has a dividend yield of 3.12%.
View Mediclinic International's dividend history.

What price target have analysts set for MDC?

3 brokerages have issued twelve-month price targets for Mediclinic International's shares. Their forecasts range from GBX 320 to GBX 323. On average, they anticipate Mediclinic International's stock price to reach GBX 321.50 in the next year. This suggests a possible upside of 8.0% from the stock's current price.
View analysts' price targets for Mediclinic International or view top-rated stocks among Wall Street analysts.

Who are Mediclinic International's key executives?

Mediclinic International's management team includes the following people:

Dr. Carel Aron van der Merwe, Group CEO & Exec. Director (Age 58, Pay $601k)
Mr. Petrus Jurgens Myburgh, Group CFO & Exec. Director (Age 46, Pay $442k)
Dr. Dirk C. Le Roux, Group Chief Information Officer (Age 61)
Mr. James Arnold, Head of Investor Relations
Mr. Magnus U. Oetiker, Group Chief Strategy and HR Officer (Age 49)
Mr. Gert C. Hattingh, Group Chief Governance Officer (Age 56)
Mr. Biren Valodia, Chief Marketing Officer of Medi-Clinic Southern Africa
Ms. Clara Findlay, Chief Legal Officer of Medicalinic Southern Africa
Mr. Wimpie Aucamp, Chief Operating Officer of Medi-Clinic for Southern Africa
Greg Van Wyk, Chief HR Officer of Medicalinic Southern Africa

Who are some of Mediclinic International's key competitors?

Some companies that are related to Mediclinic International include RHÖN-KLINIKUM Aktiengesellschaft (RHK), Spire Healthcare Group (SPI), CareTech (CTH), Georgia Healthcare Group PLC (GHG.L) (GHG), CENTRIC HEALTH (CHH), Totally (TLY), Assure (IOM), Venn Life Sciences (VENN), Widecells Group (WDC), Agility Health (AHI), (PHGI) (PHGI), American Shared Hospital Services (AMS), BLVD Centers (CXV), Brain Resource (BRC) and Cambian Group (CMBN).
View all of MDC's competitors.

What other stocks do shareholders of Mediclinic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

What is Mediclinic International's stock symbol?

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How do I buy shares of Mediclinic International?

Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mediclinic International's stock price today?

One share of MDC stock can currently be purchased for approximately GBX 297.60.

How much money does Mediclinic International make?

Mediclinic International has a market capitalization of £2.19 billion and generates £2.98 billion in revenue each year.

How many employees does Mediclinic International have?

Mediclinic International employs 32,291 workers across the globe.

What is Mediclinic International's official website?

The official website for Mediclinic International is www.mediclinic.com.

Where are Mediclinic International's headquarters?

Mediclinic International is headquartered at 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom.

How can I contact Mediclinic International?

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.

This page was last updated on 5/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here